07.10.2015
- International intellectual property regulations are doing serious damage to the pharmaceutical industry and, by extension, to the health of people around the world. The core of the...
16.12.2014
- Bayer has failed in the last round of its effort to block the sale of a cheap generic version of its cancer drug Nexavar in India. In a Dec. 12 decision, the country's Supreme...
05.08.2013
- India has revoked a patent granted to GlaxoSmithKline for breast cancer drug Tykerb, a decision that follows a landmark India court ruling disallowing patents for incremental...
02.04.2013
- India's top court dismissed Swiss drugmaker Novartis's attempt to win patent protection for its cancer drug Glivec, a blow to Western pharmaceutical firms targeting India to drive...
27.03.2013
- Global drugmakers, battered by recent intellectual property decisions in India, are girding for a landmark court ruling next week that could have broad consequences for their...
